TABLE 1.
Subject no. | Sitea | Inoculum (CFU)b | Day of biopsy | Clinical outcome | H. ducreyi detected | Reference or source |
---|---|---|---|---|---|---|
102 | P | 53 | 8 | Pustule | + | 3 |
110 | P | 60 | 14 | Pustule | + | 3 |
111 | P | 120 | 7 | Pustule | + | 28 |
121 | P | 40 | 6 | Pustule | + | 32 |
121 | M | 32 | 6 | Pustule | + | 32 |
126 | P | 40 | 8 | Pustule | + | 32 |
126 | M | 32 | 8 | Pustule | + | 32 |
127 | P | 50 | 9 | Pustule | + | 32 |
128 | P | 50 | 8 | Pustule | + | 32 |
143 | A/P | 680 | 0 | NAc | + | This study |
143 | B/P | 680 | 0 | NA | + | This study |
146 | A/P | 570 | 0 | NA | + | This study |
146 | B/P | 57 | 0 | NA | + | This study |
138 | A/P | 41 | 1 | Macule | − | This study |
138 | B/P | 41 | 1 | Papule | + | This study |
167 | A/P | 64 | 1 | Papule | − | This study |
167 | B/P | 64 | 1 | Papule | − | This study |
149 | A/P | 64 | 2 | Pustule | + | This study |
149 | B/P | 64 | 2 | Papule | + | This study |
152 | A/P | 44 | 2 | Papule | + | This study |
P, sites inoculated with H. ducreyi 35000 or 35000HP; M, sites inoculated with an isogenic mutant, A and B indicate different sites from the same subject.
Estimated delivered dose.
NA, not applicable.